BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 20463339)

  • 1. Quality indicators for colonoscopy and the risk of interval cancer.
    Kaminski MF; Regula J; Kraszewska E; Polkowski M; Wojciechowska U; Didkowska J; Zwierko M; Rupinski M; Nowacki MP; Butruk E
    N Engl J Med; 2010 May; 362(19):1795-803. PubMed ID: 20463339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.
    Kaminski MF; Wieszczy P; Rupinski M; Wojciechowska U; Didkowska J; Kraszewska E; Kobiela J; Franczyk R; Rupinska M; Kocot B; Chaber-Ciopinska A; Pachlewski J; Polkowski M; Regula J
    Gastroenterology; 2017 Jul; 153(1):98-105. PubMed ID: 28428142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
    Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
    BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting.
    Kozbial K; Reinhart K; Heinze G; Zwatz C; Bannert C; Salzl P; Waldmann E; Britto-Arias M; Ferlitsch A; Trauner M; Weiss W; Ferlitsch M
    Endoscopy; 2015 Mar; 47(3):207-16. PubMed ID: 25412094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.
    Lund M; Trads M; Njor SH; Erichsen R; Andersen B
    JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality indicators for colonoscopy and the risk of interval cancer.
    Lanspa SJ; Lynch HT
    N Engl J Med; 2010 Sep; 363(14):1371; author reply 1373. PubMed ID: 20879889
    [No Abstract]   [Full Text] [Related]  

  • 7. Colonoscopy quality assessment.
    Fayad NF; Kahi CJ
    Gastrointest Endosc Clin N Am; 2015 Apr; 25(2):373-86. PubMed ID: 25839691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in polyp detection rates at screening colonoscopy.
    Imperiale TF; Glowinski EA; Juliar BE; Azzouz F; Ransohoff DF
    Gastrointest Endosc; 2009 Jun; 69(7):1288-95. PubMed ID: 19481649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a quarterly report card on colonoscopy quality measures.
    Kahi CJ; Ballard D; Shah AS; Mears R; Johnson CS
    Gastrointest Endosc; 2013 Jun; 77(6):925-31. PubMed ID: 23472996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
    Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality indicators for colonoscopy and the risk of interval cancer.
    Chen TA
    N Engl J Med; 2010 Sep; 363(14):1372-3; author reply 1373. PubMed ID: 20886669
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
    Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
    Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?
    Ross WA; Thirumurthi S; Lynch PM; Rashid A; Pande M; Shafi MA; Lee JH; Raju GS
    Gastrointest Endosc; 2015 Mar; 81(3):567-74. PubMed ID: 25583558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of colonoscopy quality indicators with the detection of screen-relevant lesions, adverse events, and postcolonoscopy cancers in an asymptomatic Canadian colorectal cancer screening population.
    Hilsden RJ; Dube C; Heitman SJ; Bridges R; McGregor SE; Rostom A
    Gastrointest Endosc; 2015 Nov; 82(5):887-94. PubMed ID: 25952092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening.
    Jover R; Herráiz M; Alarcón O; Brullet E; Bujanda L; Bustamante M; Campo R; Carreño R; Castells A; Cubiella J; García-Iglesias P; Hervás AJ; Menchén P; Ono A; Panadés A; Parra-Blanco A; Pellisé M; Ponce M; Quintero E; Reñé JM; Sánchez del Río A; Seoane A; Serradesanferm A; Soriano Izquierdo A; Vázquez Sequeiros E; ;
    Endoscopy; 2012 Apr; 44(4):444-51. PubMed ID: 22438159
    [No Abstract]   [Full Text] [Related]  

  • 16. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
    Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
    Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
    Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
    Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance indicator of colonic intubation (PICI) in a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Njor SH; Laurberg S; Valori R; Andersen B
    Scand J Gastroenterol; 2019 Sep; 54(9):1176-1181. PubMed ID: 31498716
    [No Abstract]   [Full Text] [Related]  

  • 19. Defining and Applying Locally Relevant Benchmarks for the Adenoma Detection Rate.
    Hilsden RJ; Rose SM; Dube C; Rostom A; Bridges R; McGregor SE; Brenner DR; Heitman SJ
    Am J Gastroenterol; 2019 Aug; 114(8):1315-1321. PubMed ID: 30848731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
    Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
    Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.